| 2023-11-20 |
股东大会：
将于2023-12-19召开股东大会
会议内容 ▼▲
- 1.To adopt the Transaction Agreement, dated as of May 10, 2023, as amended by the Amendment to Transaction Agreement, dated as of August 2, 2023 and the Second Amendment to Transaction Agreement, dated as of November 5, 2023 (and as may be further amended from time to time, the “Transaction Agreement”), by and among Livent Corporation (“Livent”), Allkem Limited, an Australian public company limited by shares (“Allkem”), Arcadium Lithium plc, a public limited company incorporated under the laws of the Bailiwick of Jersey (originally incorporated as Lightning-A Limited, a private limited company incorporated under the laws of the Bailiwick of Jersey and f/k/a Allkem Livent plc) (“NewCo”) and Lightning-A Merger Sub, Inc., a Delaware company (“Merger Sub”), pursuant to which, among other transactions, Merger Sub will merge with and into Livent, with Livent surviving the merger as a wholly owned subsidiary of NewCo (the “merger”), and each share of common stock, par value $0.001 per share, of Livent (the “Livent Shares”), other than certain excluded shares, will be converted into the right to receive 2.406 ordinary shares, par value $1.00 per share, of NewCo (the “NewCo Shares”), and approve the transactions contemplated by the Transaction Agreement, including the merger (the “Livent Transaction Agreement Proposal”).
2.To approve, in a non-binding, advisory vote, the compensation that may be paid or become payable to Livent’s named executive officers in connection with the transactions contemplated by the Transaction Agreement (the “Livent Advisory Compensation Proposal”).
3.To approve, in non-binding, advisory votes, certain provisions of the articles of association of NewCo (the “NewCo Advisory Governance Documents Proposals”).
4.To approve one or more adjournments of the Livent Special Meeting to a later date or dates for any purpose if necessary or appropriate, including if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Transaction Agreement and approve the transactions contemplated thereby, including the merger, at the time of the Livent Special Meeting (the “Livent Adjournment Proposal”).
|
| 2023-11-20 |
详情>>
股本变动：
变动后总股本17981.21万股
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.63美元,归母净利润2.92亿美元,同比去年增长53.25%
|
| 2023-10-31 |
财报披露：
美东时间 2023-10-31 盘后发布财报
|
| 2023-08-04 |
详情>>
业绩披露：
2023年中报每股收益1.14美元,归母净利润2.05亿美元,同比去年增长81.10%
|
| 2023-05-04 |
详情>>
业绩披露：
2023年一季报每股收益0.64美元,归母净利润1.15亿美元,同比去年增长115.79%
|
| 2023-03-16 |
股东大会：
将于2023-04-25召开股东大会
会议内容 ▼▲
- 1.Elect three Class II directors to terms expiring in 2026.
2.Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2023.
3.Hold an advisory (non-binding) vote on named executive officer compensation.
4.Approve proposed amendments to the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws to declassify the board of directors.
5.Approve a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.
6.Consider and act upon any other business properly brought before the meeting.
|
| 2023-02-24 |
详情>>
业绩披露：
2020年年报每股收益-0.11美元,归母净利润-1630万美元,同比去年增长-132.47%
|
| 2023-02-24 |
详情>>
业绩披露：
2022年年报每股收益1.59美元,归母净利润2.73亿美元,同比去年增长45483.33%
|
| 2022-11-03 |
详情>>
业绩披露：
2022年三季报(累计)每股收益1.13美元,归母净利润1.91亿美元,同比去年增长2865.22%
|
| 2022-08-04 |
详情>>
业绩披露：
2022年中报每股收益0.69美元,归母净利润1.13亿美元,同比去年增长1885.96%
|
| 2022-08-04 |
详情>>
业绩披露：
2021年中报每股收益0.04美元,归母净利润570.00万美元,同比去年增长371.43%
|
| 2022-05-05 |
详情>>
业绩披露：
2022年一季报每股收益0.33美元,归母净利润5320.00万美元,同比去年增长6750.00%
|
| 2022-03-17 |
股东大会：
将于2022-04-26召开股东大会
会议内容 ▼▲
- 1.Elect three Class I directors to terms expiring in 2025.
2.Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2022.
3.Hold an advisory (non-binding) vote on named executive officer compensation.
4.Approve proposed amendments to the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws to declassify the board of directors.
5.Approve a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.
6.Approve a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate provisions that have become obsolete since our spin-off from FMC Corporation.
7.Consider and act upon any other business properly brought before the meeting.
|
| 2022-02-28 |
详情>>
业绩披露：
2021年年报每股收益0.00美元,归母净利润60.00万美元,同比去年增长103.68%
|
| 2021-11-04 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.05美元,归母净利润-690万美元,同比去年增长45.24%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-18 |
股东大会：
将于2021-04-29召开股东大会
会议内容 ▼▲
- 1.Elect three Class III directors to terms expiring in 2024;
2.Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2021;
3.Conduct an Advisory (Non-Binding) vote on named executive officer compensation;
4.Approve proposed amendments to the Company’s Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) and Amended and Restated By-Laws (“By-Laws”) to declassify the board of directors;
5.Approve a proposed amendment to the Company’s Certificate of Incorporation to eliminate supermajority voting requirements;
6.Conduct other business properly brought before the meeting.
|
| 2020-03-19 |
股东大会：
将于2020-04-29召开股东大会
会议内容 ▼▲
- 1.Elect three Class II directors to terms expiring in 2023.
2.Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2020.
3.Hold an advisory (non-binding) vote on the frequency of executive compensation voting.
4.Approve proposed amendments to the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws to declassify the board of directors.
5.Approve a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.
6.Consider and act upon any other business properly brought before the meeting.
|
| 2019-03-27 |
股东大会：
将于2019-05-01召开股东大会
会议内容 ▼▲
- 1.Elect two directors to serve as Class I directors for a three-year term to expire at the 2022 annual meeting of stockholders.
2.Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2019.
3.Consider and act upon any other business properly brought before the meeting.
|
| 2018-10-15 |
详情>>
内部人交易：
DALOIA G PETER等共交易8笔
|